Kanagala P, Cheng AS, Khan JN et al (2015) Unmasking the prevalence of silent myocardial infarction, ischaemia and microvascular dysfunction in HFPEF with CMR. Eur Heart J 36:538

Google Scholar 

Borlaug BA (2020) Evaluation and management of heart failure with preserved ejection fraction. Nat Rev Cardiol 17(9):559–573

Article  CAS  PubMed  Google Scholar 

D’Amario D, Migliaro S, Borovac JA et al (2019) Microvascular dysfunction in heart failure with preserved ejection fraction. Front Physiol 10:1347

Article  PubMed  PubMed Central  Google Scholar 

Fopiano KA, Jalnapurkar S, Davila AC, Arora V, Bagi Z (2022) Coronary microvascular dysfunction and heart failure with preserved ejection fraction-implications for chronic inflammatory mechanisms. Curr Cardiol Rev 18(2):e310821195986

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giamouzis G, Schelbert EB, Butler J (2016) Growing evidence linking microvascular dysfunction with heart failure with preserved ejection fraction. J Am Heart Assoc 5(2)

Lee JF, Barrett-O’Keefe Z, Garten RS et al (2016) Evidence of microvascular dysfunction in heart failure with preserved ejection fraction. Heart 102(4):278–284

Article  CAS  PubMed  Google Scholar 

Tona F, Montisci R, Iop L, Civieri G (2021) Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction. Rev Cardiovasc Med 22(1):97–104

Article  PubMed  Google Scholar 

Anker SD, Butler J, Filippatos G et al (2021) Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 385(16):1451–1461

Article  CAS  PubMed  Google Scholar 

Butler J, Packer M, Filippatos G et al (2022) Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction. Eur Heart J 43(5):416–426

Article  CAS  PubMed  Google Scholar 

Kosiborod MN, Abildstrom SZ, Borlaug BA et al (2023) Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med 389(12):1069–1084

Article  CAS  PubMed  Google Scholar 

Camici PG, Tschope C, Di Carli MF, Rimoldi O, Van Linthout S (2020) Coronary microvascular dysfunction in hypertrophy and heart failure. Cardiovasc Res 116(4):806–816

Article  CAS  PubMed  Google Scholar 

Lam CSP, Voors AA, de Boer RA, Solomon SD, van Veldhuisen DJ (2018) Heart failure with preserved ejection fraction: from mechanisms to therapies. Eur Heart J 39(30):2780–2792

Article  CAS  PubMed  Google Scholar 

Boerhout CKM, Lee JM, de Waard GA et al (2023) Microvascular resistance reserve: diagnostic and prognostic performance in the ILIAS registry. Eur Heart J 44(30):2862–2869

Article  PubMed  PubMed Central  Google Scholar 

Canto ED, van Deursen L, Hoek AG et al (2023) Microvascular endothelial dysfunction in skin is associated with higher risk of heart failure with preserved ejection fraction in women with type 2 diabetes: the Hoorn diabetes care system cohort. Cardiovasc Diabetol 22(1):234

Article  CAS  PubMed  PubMed Central  Google Scholar 

Toya T, Nagatomo Y, Ikegami Y, Masaki N, Adachi T (2023) Coronary microvascular dysfunction in heart failure patients. Frontiers in cardiovascular medicine 10:1153994

Article  CAS  PubMed  PubMed Central  Google Scholar 

Higgins JPT TJ CJ, Cumpston M, Li T, Page MJ, Welch VA (2021) Cochrane handbook for systematic reviews of interventions version 6.2 (updated February 2021). Cochrane

Page MJMJBP et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71

Article  PubMed  PubMed Central  Google Scholar 

Erik von Elm DGA, Matthias Egger et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335(7624):806–8

Ahmad A, Corban MT, Toya T et al (2021) Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction. Eur J Heart Fail 23(5):765–772

Article  CAS  PubMed  Google Scholar 

Arnold JR, Kanagala P, Budgeon CA et al (2022) Prevalence and prognostic significance of microvascular dysfunction in heart failure with preserved ejection fraction. JACC Cardiovasc Imaging

Dryer K, Gajjar M, Narang N et al (2018) Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol 314(5):H1033–H1042

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kato S, Saito N, Kirigaya H et al (2016) Impairment of coronary flow reserve evaluated by phase contrast cine-magnetic resonance imaging in patients with heart failure with preserved ejection fraction. J Am Heart Assoc 5(2)

Loffler AI, Pan JA, Balfour PC Jr et al (2019) Frequency of coronary microvascular dysfunction and diffuse myocardial fibrosis (measured by cardiovascular magnetic resonance) in patients with heart failure and preserved left ventricular ejection fraction. Am J Cardiol 124(10):1584–1589

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mahfouz RA, Gouda M, Abdelhamid M (2020) Relation of microvascular dysfunction and exercise tolerance in patients with heart failure with preserved ejection fraction. Echocardiography 37(8):1192–1198

Article  PubMed  Google Scholar 

Rush CJ, Berry C, Oldroyd KG et al (2021) Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. JAMA Cardiol 6(10):1130–1143

Article  PubMed  Google Scholar 

Shah SJ, Lam CSP, Svedlund S et al (2018) Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J 39(37):3439–3450

Article  CAS  PubMed  PubMed Central  Google Scholar 

Srivaratharajah K, Coutinho T, deKemp R et al (2016) Reduced myocardial flow in heart failure patients with preserved ejection fraction. Circ Heart Fail 9(7)

Yang JH, Obokata M, Reddy YNV, Redfield MM, Lerman A, Borlaug BA (2020) Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Eur J Heart Fail 22(3):432–441

Article  CAS  PubMed  Google Scholar 

Allan T, Dryer K, Fearon WF, Shah SJ, Blair JEA (2019) Coronary microvascular dysfunction and clinical outcomes in patients with heart failure with preserved ejection fraction. J Card Fail 25(10):843–845

Article  PubMed  Google Scholar 

Paulus WJTC (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62(4):263–271

Article  PubMed  Google Scholar 

Sucato V, Evola S, Novo G et al (2015) Angiographic evaluation of coronary microvascular dysfunction in patients with heart failure and preserved ejection fraction. Microcirculation 22(7):528–533

Article  PubMed  Google Scholar 

Mohammed SF, Hussain S, Mirzoyev SA, Edwards WD, Maleszewski JJ, Redfield MM (2015) Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Circulation 131(6):550–559

Article  PubMed  Google Scholar 

Kelshiker MA, Seligman H, Howard JP et al (2022) Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis. Eur Heart J 43(16):1582–1593

Article  PubMed  Google Scholar 

Gdowski MA, Murthy VL, Doering M, Monroy-Gonzalez AG, Slart R, Brown DL (2020) Association of isolated coronary microvascular dysfunction with mortality and major adverse cardiac events: a systematic review and meta-analysis of aggregate data. J Am Heart Assoc 9(9):e014954

Article  CAS  PubMed  PubMed Central  Google Scholar 

McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726

Article  CAS  PubMed  Google Scholar 

Diabetes GBD, Air Pollution C (2022) Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM(2.5) air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019. Lancet Planet Health 6(7):e586-e600.

Haagsma JA, James SL, Castle CD et al (2020) Burden of injury along the development spectrum: associations between the Socio-demographic index and disability-adjusted life year estimates from the Global burden of disease study 2017. Inj Prev 26(Supp 1):i12–i26

Article  PubMed  Google Scholar 

Jakovljevic M, Chang H, Pan J et al (2023) Successes and challenges of China’s health care reform: a four-decade perspective spanning 1985–2023. Cost Eff Resour Alloc 21(1):59

Article  PubMed  PubMed Central  Google Scholar 

Jakovljevic M, Fernandes PO, Teixeira JP, Rancic N, Timofeyev Y, Reshetnikov V (2019) Underlying differences in health spending within the world health organisation europe region-comparing EU15, EU Post-2004, CIS, EU Candidate, and CARINFONET Countries. Int J Environ Res Public Health 16(17)

Jakovljevic M, Groot W, Souliotis K (2016) Editorial: health care financing and affordability in the emerging global markets. Front Public Health 4:2

Article  PubMed  PubMed Central  Google Scholar 

Jakovljevic M, Timofeyev Y, Ekkert NV et al (2019) The impact of health expenditures on public health in BRICS nations. J Sport Health Sci 8(6):516–519

Article  PubMed  PubMed Central  Google Scholar 

Jakovljevic MB, Milovanovic O (2015) Growing burden of non-communicable diseases in the emerging health markets: the case of BRICS. Front Public Health 3:65

Article  PubMed  PubMed Central  Google Scholar 

Katoue MG, Cerda AA, Garcia LY, Jakovljevic M (2022) Healthcare system development in the Middle East and North Africa region: challenges, endeavors and prospective opportunities. Front Public Health 10:1045739

Article  PubMed  PubMed Central